Anyone with a serious underlying health condition or compromised immune system should seek provider guidance before starting probiotics
The main benefits of GLP-1 therapy include: Enhanced insulin secretion in response to meals Reduced glucagon release, preventing high blood sugar levels Slowed gastric emptying, leading to prolonged satiety Decreased appetite, which may help with weight loss Currently available GLP-1 receptor agonists include drugs like liraglutide (Victoza), semaglutide (Ozempic, Wegovy), exenatide (Byetta), and dulaglutide (Trulicity)
Finally, we discuss translational gaps including scalability, regulatory hurdles, and patient-specific variability that must be addressed for successful clinical implementation
However, these trials did not specifically recruit individuals with diagnosed BED, and eating disorder symptoms were not primary outcomes
doi: 10.1186/s12951-024-02911-9 73 LiWFengJPengJZhangXAzizAURWangD